X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,202 | -0.8% | 10,277 | +76.6% | 0.00% | – |
| Q2 2023 | $11,293 | +1129200.0% | 5,821 | +618.6% | 0.00% | – |
| Q1 2023 | $1 | -90.0% | 810 | -92.1% | 0.00% | – |
| Q4 2022 | $10 | -99.8% | 10,227 | +81.4% | 0.00% | – |
| Q2 2022 | $5,000 | -68.8% | 5,639 | -41.8% | 0.00% | – |
| Q1 2022 | $16,000 | +128.6% | 9,695 | +675.6% | 0.00% | – |
| Q3 2021 | $7,000 | -91.9% | 1,250 | -90.6% | 0.00% | -100.0% |
| Q2 2021 | $86,000 | +230.8% | 13,231 | +337.7% | 0.00% | – |
| Q1 2021 | $26,000 | -33.3% | 3,023 | -50.6% | 0.00% | -100.0% |
| Q4 2020 | $39,000 | -67.2% | 6,124 | -65.2% | 0.00% | 0.0% |
| Q3 2020 | $119,000 | +310.3% | 17,588 | +470.7% | 0.00% | 0.0% |
| Q2 2020 | $29,000 | -3.3% | 3,082 | +54.6% | 0.00% | -50.0% |
| Q2 2019 | $30,000 | +275.0% | 1,994 | +343.1% | 0.00% | – |
| Q1 2019 | $8,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |